DOI: 10.1016/0922-4106(94)90047-7. Clozapine is a potent and selective muscarinic M4 receptor agonist

Clozapine is a potent and selective muscarinic M4 receptor agonist

10.1016/0922-4106(94)90047-7

Crossref journal-article

Elsevier BV

European Journal of Pharmacology: Molecular Pharmacology (78)

Bibliography

Zorn, S. H., Jones, S. B., Ward, K. M., & Liston, D. R. (1994). Clozapine is a potent and selective muscarinic M4 receptor agonist. European Journal of Pharmacology: Molecular Pharmacology, 269(3), R1âR2.

Authors 4

Stevin H. Zorn (first)
Shawn B. Jones (additional)
Karen M. Ward (additional)
Dane R. Liston (additional)

References 8 Referenced 138

10.1016/0014-2999(91)90096-9 / Eur. J. Pharmacol. / Clozapine is a potent and selective muscarinic antagonist at the five cloned human muscarinic acetylcholine receptors expressed in CHO-K1 cells by Bolden (1991)
10.1016/0014-5793(88)80648-3 / FEBS Lett. / The striatum and cerebral cortex express different muscarinic receptor mRNAs by Brann (1988)
{'key': '10.1016/0922-4106(94)90047-7_BIB3', 'first-page': '459', 'article-title': 'Immunological detection of muscarinic receptor subtype proteins (m1-m5) in rabbit peripheral tissues', 'volume': '40', 'author': 'Dorje', 'year': '1992', 'journal-title': 'Mol. Pharmacol.'} / Mol. Pharmacol. / Immunological detection of muscarinic receptor subtype proteins (m1-m5) in rabbit peripheral tissues by Dorje (1992)
{'key': '10.1016/0922-4106(94)90047-7_BIB4', 'first-page': '1452', 'article-title': 'Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine', 'volume': '268', 'author': 'Meltzer', 'year': '1994', 'journal-title': 'J. Pharmacol. Exp. Ther.'} / J. Pharmacol. Exp. Ther. / Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine by Meltzer (1994)
10.1038/248596a0 / Nature / Antimuscarinic properties of neuroleptics and drug-induced Parkinsonism by Miller (1974)
10.1111/j.1476-5381.1991.tb12412.x / Br. J. Pharmacol. / Muscarinic antagonists attenuate the increase in accumbens and striatum dopamine metabolism produced by clozapine but not by haloperidol by Rivest (1991)
10.1001/archpsyc.1974.01760130040006 / Arch. Gen. Psychiatry / Antipsychotic drugs and brain cholinergic receptors: affinity for muscarinic sites predicts extrapyramidal effects by Snyder (1974)
10.1001/archpsyc.1993.01820140084012 / Arch. Gen. Psychiatry / Neuropharmacologic basis for clozapine's unique profile by Tandon (1993)

Dates

Type	When
Created	22 years, 8 months ago (Dec. 13, 2002, 11:03 p.m.)
Deposited	6 years, 4 months ago (April 1, 2019, 6:23 a.m.)
Indexed	3 days, 14 hours ago (Aug. 24, 2025, 6:59 p.m.)
Issued	30 years, 9 months ago (Nov. 1, 1994)
Published	30 years, 9 months ago (Nov. 1, 1994)
Published Print	30 years, 9 months ago (Nov. 1, 1994)

Funders 0

None

BibTeX

@article{Zorn_1994, title={Clozapine is a potent and selective muscarinic M4 receptor agonist}, volume={269}, ISSN={0922-4106}, url={http://dx.doi.org/10.1016/0922-4106(94)90047-7}, DOI={10.1016/0922-4106(94)90047-7}, number={3}, journal={European Journal of Pharmacology: Molecular Pharmacology}, publisher={Elsevier BV}, author={Zorn, Stevin H. and Jones, Shawn B. and Ward, Karen M. and Liston, Dane R.}, year={1994}, month=nov, pages={R1–R2} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        8,
        24
      ]
    ],
    "date-time": "2025-08-24T22:59:43Z",
    "timestamp": 1756076383649
  },
  "reference-count": 8,
  "publisher": "Elsevier BV",
  "issue": "3",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            1994,
            11,
            1
          ]
        ],
        "date-time": "1994-11-01T00:00:00Z",
        "timestamp": 783648000000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        1994,
        11
      ]
    ]
  },
  "DOI": "10.1016/0922-4106(94)90047-7",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2002,
        12,
        14
      ]
    ],
    "date-time": "2002-12-14T04:03:24Z",
    "timestamp": 1039838604000
  },
  "page": "R1-R2",
  "source": "Crossref",
  "is-referenced-by-count": 138,
  "title": "Clozapine is a potent and selective muscarinic M4 receptor agonist",
  "prefix": "10.1016",
  "volume": "269",
  "author": [
    {
      "given": "Stevin H.",
      "family": "Zorn",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Shawn B.",
      "family": "Jones",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Karen M.",
      "family": "Ward",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Dane R.",
      "family": "Liston",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "key": "10.1016/0922-4106(94)90047-7_BIB1",
      "doi-asserted-by": "crossref",
      "first-page": "205",
      "DOI": "10.1016/0014-2999(91)90096-9",
      "article-title": "Clozapine is a potent and selective muscarinic antagonist at the five cloned human muscarinic acetylcholine receptors expressed in CHO-K1 cells",
      "volume": "192",
      "author": "Bolden",
      "year": "1991",
      "journal-title": "Eur. J. Pharmacol."
    },
    {
      "key": "10.1016/0922-4106(94)90047-7_BIB2",
      "doi-asserted-by": "crossref",
      "first-page": "90",
      "DOI": "10.1016/0014-5793(88)80648-3",
      "article-title": "The striatum and cerebral cortex express different muscarinic receptor mRNAs",
      "volume": "230",
      "author": "Brann",
      "year": "1988",
      "journal-title": "FEBS Lett."
    },
    {
      "key": "10.1016/0922-4106(94)90047-7_BIB3",
      "first-page": "459",
      "article-title": "Immunological detection of muscarinic receptor subtype proteins (m1-m5) in rabbit peripheral tissues",
      "volume": "40",
      "author": "Dorje",
      "year": "1992",
      "journal-title": "Mol. Pharmacol."
    },
    {
      "key": "10.1016/0922-4106(94)90047-7_BIB4",
      "first-page": "1452",
      "article-title": "Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine",
      "volume": "268",
      "author": "Meltzer",
      "year": "1994",
      "journal-title": "J. Pharmacol. Exp. Ther."
    },
    {
      "key": "10.1016/0922-4106(94)90047-7_BIB5",
      "doi-asserted-by": "crossref",
      "first-page": "596",
      "DOI": "10.1038/248596a0",
      "article-title": "Antimuscarinic properties of neuroleptics and drug-induced Parkinsonism",
      "volume": "248",
      "author": "Miller",
      "year": "1974",
      "journal-title": "Nature"
    },
    {
      "key": "10.1016/0922-4106(94)90047-7_BIB6",
      "doi-asserted-by": "crossref",
      "first-page": "234",
      "DOI": "10.1111/j.1476-5381.1991.tb12412.x",
      "article-title": "Muscarinic antagonists attenuate the increase in accumbens and striatum dopamine metabolism produced by clozapine but not by haloperidol",
      "volume": "104",
      "author": "Rivest",
      "year": "1991",
      "journal-title": "Br. J. Pharmacol."
    },
    {
      "key": "10.1016/0922-4106(94)90047-7_BIB7",
      "doi-asserted-by": "crossref",
      "first-page": "58",
      "DOI": "10.1001/archpsyc.1974.01760130040006",
      "article-title": "Antipsychotic drugs and brain cholinergic receptors: affinity for muscarinic sites predicts extrapyramidal effects",
      "volume": "31",
      "author": "Snyder",
      "year": "1974",
      "journal-title": "Arch. Gen. Psychiatry"
    },
    {
      "key": "10.1016/0922-4106(94)90047-7_BIB8",
      "doi-asserted-by": "crossref",
      "first-page": "158",
      "DOI": "10.1001/archpsyc.1993.01820140084012",
      "article-title": "Neuropharmacologic basis for clozapine's unique profile",
      "volume": "50",
      "author": "Tandon",
      "year": "1993",
      "journal-title": "Arch. Gen. Psychiatry"
    }
  ],
  "container-title": "European Journal of Pharmacology: Molecular Pharmacology",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:0922410694900477?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:0922410694900477?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2019,
        4,
        1
      ]
    ],
    "date-time": "2019-04-01T10:23:04Z",
    "timestamp": 1554114184000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/0922410694900477"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        1994,
        11
      ]
    ]
  },
  "references-count": 8,
  "journal-issue": {
    "issue": "3",
    "published-print": {
      "date-parts": [
        [
          1994,
          11
        ]
      ]
    }
  },
  "alternative-id": [
    "0922410694900477"
  ],
  "URL": "http://dx.doi.org/10.1016/0922-4106(94)90047-7",
  "relation": {},
  "ISSN": [
    "0922-4106"
  ],
  "subject": [],
  "container-title-short": "European Journal of Pharmacology: Molecular Pharmacology",
  "published": {
    "date-parts": [
      [
        1994,
        11
      ]
    ]
  }
}